<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Leishmania</italic> (
 <italic>Viannia</italic>) 
 <italic>panamensi</italic>s is an important causal agent of cutaneous leishmaniasis (CL) in Central and South America [
 <xref rid="ref2" ref-type="bibr">2</xref>] and approximately 0.7-1.2 million cases occur annually. Different forms of leishmaniasis demand expensive treatments, the currently used medicines pentavalent antimonials, pentamidine isethionate, and miltefosine show high toxicity; therefore, they induce severe side effects. Thus, there is an urgency to develop new drugs to treat CL [
 <xref rid="ref3" ref-type="bibr">3</xref>].
</p>
